Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, is investigating Aegerion Pharmaceuticals, Inc. for securities fraud following the news that the company illegally engaged in off-label marketing schemes and advises investors of the class-action lead plaintiff deadline on March 17, 2014.
http://ift.tt/1fkluvi
http://ift.tt/1fkluvi
No comments:
Post a Comment